₹ 3200
10% OFF for Senior Citizens | USE CODE SS10 *
@3x.png)
Description
The ROMA (Risk of Ovarian Malignancy Algorithm) test is widely used to determine the likelihood of ovarian cancer in women with ovarian mass. The ROMA blood test measures HE4 and CA125 biomarker levels, combined with menopausal status. Women with ovarian mass or symptoms like pelvic pain and bloating must consider taking a ROMA test for early detection.
Ovarian cancer is one of the most serious and challenging gynaecological concerns to detect early, as various symptoms like bloating, abdominal discomfort and pelvic pain are often experienced only in the later stages. Early detection through a ROMA test significantly helps improve treatment outcomes, making risk assessment crucial for women with risk potential. The test determines the likelihood of ovarian cancer through two key biomarkers, namely HE4 and CA125, along with menopausal status.
The ROMA blood test classifies women with an ovarian mass into low or high-risk categories, guiding healthcare professionals in determining further diagnostic steps like biopsy or imaging. While the ROMA index test does not guide doctors toward a definitive diagnosis, it enhances ovarian cancer risk assessment and supports clinical decisions. Women experiencing persistent symptoms must seek consultation without delay and book a ROMA lab test for timely evaluation. For timely and accurate ROMA test results, consider Max Lab, which offers reliable diagnostic services at a competitive ROMA test price for better healthcare outcomes.
....Read More
Recommended Tests
FAQs
Description
The ROMA (Risk of Ovarian Malignancy Algorithm) test is widely used to determine the likelihood of ovarian cancer in women with ovarian mass. The ROMA blood test measures HE4 and CA125 biomarker levels, combined with menopausal status. Women with ovarian mass or symptoms like pelvic pain and bloating must consider taking a ROMA test for early detection.
Ovarian cancer is one of the most serious and challenging gynaecological concerns to detect early, as various symptoms like bloating, abdominal discomfort and pelvic pain are often experienced only in the later stages. Early detection through a ROMA test significantly helps improve treatment outcomes, making risk assessment crucial for women with risk potential. The test determines the likelihood of ovarian cancer through two key biomarkers, namely HE4 and CA125, along with menopausal status.
The ROMA blood test classifies women with an ovarian mass into low or high-risk categories, guiding healthcare professionals in determining further diagnostic steps like biopsy or imaging. While the ROMA index test does not guide doctors toward a definitive diagnosis, it enhances ovarian cancer risk assessment and supports clinical decisions. Women experiencing persistent symptoms must seek consultation without delay and book a ROMA lab test for timely evaluation. For timely and accurate ROMA test results, consider Max Lab, which offers reliable diagnostic services at a competitive ROMA test price for better healthcare outcomes.
....Read MoreThe ROMA (Risk of Ovarian Malignancy Algorithm) test is widely used to determine the likelihood of ovarian cancer in women with ovarian mass. The ROMA blood test measures HE4 and CA125 biomarker levels, combined with menopausal status.
The test is prescribed when a doctor identifies an ovarian mass through an ultrasound or other imaging tests and needs to determine the next course of action. A ROMA test for ovarian cancer is also helpful in distinguishing between benign and malignant tumours early enough for timely intervention. Women who experience frequent episodes of bloating, abdominal swelling, pelvic pain or unexplained weight loss may need to undergo a ROMA index test for further evaluation.
Doctors may also recommend undergoing the test if an individual is at a higher risk of ovarian cancer, particularly those with a family history of the disease or genetic predisposition, like BRCA1 or BRCA2 mutations. The ROMA test results are analysed alongside other clinical findings to provide a comprehensive risk assessment.
For a precise and prompt ROMA test report, book an at-home sample collection by Max Lab. With skilled sample handling and state-of-the-art diagnostics, Max Lab ensures your health is in good hands.
The ROMA blood test results are typically available within 24 hours after a successful sample collection, allowing for a rapid and effective evaluation of the risk of ovarian cancer. Once the ROMA test results are ready, one may download them conveniently online from the Max Lab website or mobile application, making it simple and convenient for both individuals and their doctors.
After receiving the ROMA lab test interpretation, it is advisable to speak to a healthcare professional for further course of action. Based on ROMA score test results, doctors may suggest further testing, monitoring or immediate medical intervention if the risk of malignancy is present or is severely high. One may schedule a cost-effective ROMA test with Max Lab, assisting them in making well-informed health decisions with their healthcare professional’s expert guidance.
Myeloma, also known as Kahler’s Disease, is a type of cancer that devel...
Skin cancer is one of the most common types of cancer globally, affecting mil...
Prostate cancer (PCa) is one of the most common cancers foun...
.png)
7982100200
Test Name 
Sample Type 
Gender 
Age group 
This Test Includes 
Price
To reach our help desk call 9213188888